Mark Labrecque Email and Phone Number
Mark Labrecque personal email
- Valid
Mark Labrecque phone numbers
Accomplished Regional Account Manager and Clinical Science Sales Specialist in both the Biopharmaceutical and Medical Device Industries. Clinical experience in Pediatric and Adult Hepatology/Gastroenterology, Diabetes and Endocrinology, Lipidology, Medical Genetics, Pathology, Pulmonary and Critical Care, Cardiology, Lysosomal Storage Disease Centers, Metabolic Bone Clinics, and Rare Disease. I am well respected in the medical community (especially in the teaching institutions throughout New England) as both a passionate and compassionate patient advocate and responsive, knowledgeable clinical partner to my customers.Key Areas of Expertise:Evidence based Bio-pharmaceutical and Medical sales to specialists, clinics, hospitals and teaching institutions.Development of new patient protocols.Development of Regional and National KOL's (especially in Boston).Patient specific demand creation in Rare and Orphan diseases.First in class product launches.Patient Access programs.Identifying patients for Clinical Trials and Research projects.Close partnerships with KOL's, Specialists, Caregivers, Case Managers, Patients and Families.Territory Business Planning, Management, and Financial Analysis. Excellent interpersonal, communication, and consultative selling skills.Specialties: Formal training in TAS (Target Account Selling), SPIN Selling, Strategic Account Selling and Consultative Sales.
Eton Pharmaceuticals
View- Website:
- etonpharma.com
- Employees:
- 51
-
National Sales Director - Metabolics And HepatologyEton PharmaceuticalsBoston, Ma, Us
-
National Sales Manager - Metabolics And HepatologyEton PharmaceuticalsBoston, Ma, Us
-
Key Account Manager - Metabolic Liver - Boston And NycOrphalan Dec 2023 - PresentParis, Île-De-France, FrUltra Rare Disease - Business Development - Genetics - Hepatology - Gastroenterology -
Senior Clinical Account ManagerTravere Therapeutics Feb 2017 - Dec 2023San Diego, California, UsBile Acid Portfolio Acquired by Mirum Pharmaceuticals from Travere Therapeutics in September 2023. Deliver life changing therapies to children and adults living with ultra rare diseases. Covering all of New England and New York. Focus on large institutions and academic centers. Genetic testing and results interpretation. Calling on Pediatric Hepatology-Gastroenterology, Neonatology, Pediatric Ophthalmology, Adult/Pediatric Genetics, Adult/Pediatric Neurology, Hospital pharmacy and Laboratory. -
Regional Account Manager - Metabolics DivisionAlexion Pharmaceuticals, Inc. Jun 2015 - Sep 2016Boston, Massachusetts, UsAlexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Patients with these life threatening diseases often have no effective treatment options, and they and there families suffer with little hope. Our goal is to deliver medical breakthroughs where none currently exist. Synageva become part of Alexion in June of 2015 - I currently work throughout New England with academic institutions and various specialists (Pediatric and Adult Hepatology, Lipidology, Genetics, Gastroenterology, Endocrinology, Pathology, Lysosomal Storage Disease centers, and Metabolic Bone Specialists) to help them identify and diagnose patients and families suffering from Lysosomal Acid Lipase Deficiency (LAL-D) and Hypophosphatasia (HPP).Responsible for the sales of Kanuma and Strensiq: both ultra orhan enzyme replacement therapies. -
Clinical Science ManagerSynageva Biopharma Corp. Dec 2013 - Jun 2015Lexington, Massachusetts, UsSynageva is a start-up biopharmaceutical company dedicated to discovering, developing, and delivering medicines for patients with rare diseases and high unmet medical needs. We are passionate about our commitment to improving the lives of patients for generations to come and believe that every patient deserves a treatment option, no matter how rare their disease.Territory included all of New England, NY (NYC and Upstate) and NJ. Responsible for all pre-commercial activities including territory development, KOL initiatives, research and testing projects, and disease awareness and education in Lysosomal Acid Lipase Deficiency (LAL-D), an ultra rare genetic condition characterized by decreased LAL enzyme activity in the lysosomes across multiple body tissues leading to the build up of fatty material in the liver, blood vessels and other tissues. LAL-D is fatal when presenting in infants and leads to significant morbidity and early mortality in children and adults.Synageva was acquired by Alexion in June of 2015. -
Clinical Science SpecialistIpsen Jun 2010 - Dec 2013Boulogne Billancourt, Fr2011 "Circle of Excellence" winner (TOP 2 in the country). 2011 Growth Club Winner (largest percentage growth year over year). Biotechnology Sales Specialist covering the six New England states. Responsibilities include calling on Neuro-Endocrinology and Hospital pharmacies at major teaching institutions in Boston and throughout New England. Rare growth diseases (Acromegaly and Severe Primary IGF-1 Deficiency) was my primary focus. Responsibilities were patient identification and the sales of 2 pharmaceuticals in a complicated reimbursement arena. -
Account ExecutiveGlobal Healthcare Exchange Sep 2008 - Apr 2010Louisville, Co, UsSold Supply Chain Management software and consulting services to hospitals. Accounts utilized company for: supply chain automation, sales force performance enhancement, rebate and claim management, market share reporting, and business intelligence. At the core of all services is the internet trading exchange (open to all members of the healthcare supply chain) including: hospitals, suppliers, distributors, and group purchasing organizations (GPO’s). -
Diabetes Management ConsultantMedtronic Feb 2006 - Aug 2008Minneapolis, Mn, UsSuccessfully sold “Continuous Subcutaneous Insulin Infusion” (insulin pumps) and Continuous Glucose Monitoring systems. Aggressively developed an underperforming territory into a leading territory in the nation, while taking on a leadership role within the Northeast region. Achievements include:Exceptional Achiever Award for FY ’07 (Top 10% out of TM's in the USA).FY ‘07: ranked #6 to quota (161% to plan), #2 with 108.5% revenue of prior year (double prior year’s results).Brought territory from #146 to #15 while exceeding revenue goal by over $700,000.00 (+ 161% to plan).Hard Charger Award Q2 for Northeast region.(Mentored Alex Koslowsky to achieve "IPS of the year").Changed 393 lives of patients and brought in 539 opportunities (goal was 245 and 321 respectively). Sold 393 pumps in FY ‘07 (original goal was 245!). -
Immunology Sales SpecialistIntermune Apr 2001 - Nov 2005Successfully managed business development activities for both existing and new hospital accounts selling; Gamma Interferon, Alpha Interferon, and Amphotec. Sold to: Gastroenterology, Pulmonary, Critical Care, Hepatology, Infectious Disease, and Oncology. Developed key opinion leaders, product champions, and speakers for company products. Assisted in the hiring and training of new sales representatives. Achievements included:Finished 2002 ranked #9 overall.Increased territory sales of Actimmune from $1.6M to $1.9M in 2003 and from $624,000 to $1.6M in 2002.Ranked #12 nationally (out of 86) for Infergen and #4 for Amphotec in 2003. Ranked #15 for Amphotec and #39 for Infergen in 2002.Appointed to Marketing Advisory Panel Specialist by Sales Director in 2003 (Northeast Region). Developed selling strategies for indications within managed markets, specialty pharmacy, and Orphan Drug market. -
Pharmaceutical Sales Specialist And District TrainerAstrazeneca 1997 - 2000Sold pharmaceuticals into Pulmonary, Allergy, and Primary care. Trained new representatives.Achievements included:Finished 2000 ranked #4 overall (President’s Club Winner).Achieved quotas of 121%, 111%, and 102% for product portfolio in the year 2000.Increased territory sales from $1.2 million to $1.7 million in 1999 and from $671,500 to $1.2 million in 1998.Worked in a District that finished 2nd in 1998 President’s Club (57 National Districts).Attained top 12 positioning for launch of flagship product in 1998 (over 100% of quota).
Mark Labrecque Skills
Mark Labrecque Education Details
-
Unh Peter T. Paul College Of Business And EconomicsGeneral
Frequently Asked Questions about Mark Labrecque
What company does Mark Labrecque work for?
Mark Labrecque works for Eton Pharmaceuticals
What is Mark Labrecque's role at the current company?
Mark Labrecque's current role is National Sales Director - Metabolics and Hepatology.
What is Mark Labrecque's email address?
Mark Labrecque's email address is mg****@****hoo.com
What is Mark Labrecque's direct phone number?
Mark Labrecque's direct phone number is +160349*****
What schools did Mark Labrecque attend?
Mark Labrecque attended Unh Peter T. Paul College Of Business And Economics.
What skills is Mark Labrecque known for?
Mark Labrecque has skills like Biotechnology, Pharmaceutical Industry, Product Launch, Pharmaceutical Sales, Cardiology, Hospitals, Medical Devices, Selling, Sales Effectiveness, Sales, Orphan Drugs, Neurology.
Who are Mark Labrecque's colleagues?
Mark Labrecque's colleagues are Skye C., Heidi Corvo, Alfredo Alfonso-Garciarena, Alfredo Alfonso-Garciarena, Morgan Brynjelsen, Katie Vedder, Christopher Dooley.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial